BIOMARIN PHARMACEUTICAL INC - COM (BMRN)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
181 M
Holdings value Q1 2024
$15.8 B
Value change Q1 2024
-$275 M
Grand Portfolio weight change Q1 2024
-0.001%
Number of holders
522
Number of buys Q1 2024
239
Number of sells Q1 2024
-240
Average buys Q1 2024 %
+0.008%
Average sells Q1 2024 %
-0.004%
CUSIP
09061G101
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 181 M $15.8 B -$275 M $87.34 522
2023 Q4 184 M $17.7 B +$542 M $96.42 516
2023 Q3 177 M $15.7 B +$286 M $88.48 502
2023 Q2 171 M $14.8 B -$352 M $86.68 534
2023 Q1 175 M $17 B -$406 M $97.24 533
2022 Q4 181 M $18.8 B +$42.4 M $103.49 561
2022 Q3 180 M $15.3 B +$296 M $84.77 523
2022 Q2 178 M $14.7 B +$129 M $82.87 507
2022 Q1 175 M $13.5 B +$11.6 M $77.10 526
2021 Q4 174 M $15.4 B +$129 M $88.35 530
2021 Q3 175 M $13.5 B +$32.4 M $77.29 492
2021 Q2 174 M $14.5 B -$129 M $83.44 501
2021 Q1 175 M $13.2 B -$350 M $75.51 506
2020 Q4 179 M $15.7 B +$287 M $87.69 511
2020 Q3 178 M $13.6 B -$312 M $76.08 473
2020 Q2 180 M $22.2 B +$737 M $123.34 514
2020 Q1 174 M $14.7 B +$281 M $84.50 468
2019 Q4 173 M $14.6 B +$51.1 M $84.55 444
2019 Q3 173 M $11.7 B -$330 M $67.40 420
2019 Q2 177 M $15.2 B +$318 M $85.65 461
2019 Q1 178 M $15.8 B -$68.8 M $88.83 468
2018 Q4 179 M $15.2 B -$188 M $85.15 454
2018 Q3 181 M $17.5 B -$164 M $96.97 445
2018 Q2 182 M $17.2 B +$327 M $94.20 432
2018 Q1 179 M $14.5 B +$217 M $81.07 418
2017 Q4 176 M $15.7 B +$262 M $89.17 424
2017 Q3 175 M $16.2 B +$328 M $93.07 404
2017 Q2 169 M $15.3 B +$171 M $90.82 416
2017 Q1 169 M $14.8 B +$934 M $87.78 410
2016 Q4 169 M $14 B +$54.3 M $82.84 402
2016 Q3 168 M $15.5 B +$821 M $92.52 419
2016 Q2 158 M $12.3 B -$246 M $77.80 385
2016 Q1 161 M $13.3 B +$260 M $82.48 377
2015 Q4 166 M $16.9 B +$174 M $104.76 382
2015 Q3 159 M $16.8 B +$90.3 M $105.32 387
2015 Q2 156 M $21.3 B +$182 M $136.78 388
2015 Q1 157 M $19.5 B +$1.28 B $124.62 377
2014 Q4 148 M $13.3 B +$113 M $90.40 336
2014 Q3 148 M $10.7 B +$241 M $72.16 312
2014 Q2 144 M $8.96 B -$420 M $62.21 319
2014 Q1 147 M $10 B +$474 M $68.21 307